{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T11:52:26Z","timestamp":1763725946523},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2005,7,13]],"date-time":"2005-07-13T00:00:00Z","timestamp":1121212800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1007\/s00280-005-1030-3","type":"journal-article","created":{"date-parts":[[2005,7,12]],"date-time":"2005-07-12T17:10:20Z","timestamp":1121188220000},"page":"585-593","source":"Crossref","is-referenced-by-count":32,"title":["Signal transduction through substance P receptor in human glioblastoma cells: roles for Src and PKC\u03b4"],"prefix":"10.1007","volume":"56","author":[{"given":"Keisuke","family":"Yamaguchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark D.","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darrell D.","family":"Bigner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madan M.","family":"Kwatra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,7,13]]},"reference":[{"key":"1030_CR1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1152\/physrev.1993.73.2.229","volume":"73","author":"M Otsuka","year":"1993","unstructured":"Otsuka M, Yoshioka K (1993) Neurotransmitter functions of mammalian tachykinins. Physiol Rev 73:229\u2013308","journal-title":"Physiol Rev"},{"key":"1030_CR2","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0024-3205(00)00692-5","volume":"67","author":"C Palma","year":"2000","unstructured":"Palma C, Maggi CA (2000) The role of tachykinins via NK1 receptors in progression of human gliomas. Life Sci 67:985\u20131001","journal-title":"Life Sci"},{"key":"1030_CR3","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/ijc.2910610608","volume":"61","author":"IM Hennig","year":"1995","unstructured":"Hennig IM, Laissue JA, Horisberger U, Reubi JC (1995) Substance-P receptors in human primary neoplasms: tumoral and vascular localization. Int J Cancer 61:786\u2013792","journal-title":"Int J Cancer"},{"key":"1030_CR4","first-page":"4983","volume":"56","author":"W Luo","year":"1996","unstructured":"Luo W, Sharif TR, Sharif M (1996) Substance P-induced mitogenesis in human astrocytoma cells correlates with activation of the mitogen-activated protein kinase signaling pathway. Cancer Res 56: 4983\u20134991","journal-title":"Cancer Res"},{"key":"1030_CR5","first-page":"236","volume":"79","author":"C Palma","year":"1999","unstructured":"Palma C, Nardelli F, Manzini S, Maggi CA (1999) Substance P activates responses correlated with tumour growth in human glioma lines bearing tachykinin NK1 receptors. Br J Pharmacol 79:236\u2013243","journal-title":"Br J Pharmacol"},{"key":"1030_CR6","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0304-3940(94)90644-0","volume":"171","author":"C Palma","year":"1994","unstructured":"Palma C, Goso C, Manzini S (1994) Different susceptibility to neurokinin 1 receptor antagonists of substance P and septide-induced interleukin-6 release from U373 MG human astrocytoma cell line. Neurosci Lett 171:221\u2013224","journal-title":"Neurosci Lett"},{"key":"1030_CR7","first-page":"269","volume-title":"Cytokines and the CNS","author":"GY Gillespie","year":"1996","unstructured":"Gillespie GY (1996) Cytokines as modulators of malignant glioma progression. In: Ransohoff RM, Beneviste EM (eds) Cytokines and the CNS.CRC Press, Boca Raton, pp 269\u2013286"},{"key":"1030_CR8","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1471-4159.1992.tb09745.x","volume":"58","author":"CL Johnson","year":"1992","unstructured":"Johnson CL, Johnson CG (1992) Characterization of receptors for substance P in human astrocytoma cells: radioligand binding and inositol phosphate formation. J Neurochem 58:471\u2013477","journal-title":"J Neurochem"},{"key":"1030_CR9","first-page":"1225","volume":"8","author":"W Luo","year":"1997","unstructured":"Luo W, Sharif TR, Houghton PJ, Sharif M (1997) CGP 4125 and tamoxifen selectively inhibit mitogen-activated protein kinase activation and c-Fos phosphoprotein induction by substance P in human astrocytoma cells. Cell Growth Diff 8:1225\u20131240","journal-title":"Cell Growth Diff"},{"key":"1030_CR10","doi-asserted-by":"crossref","first-page":"5606","DOI":"10.4049\/jimmunol.165.10.5606","volume":"165","author":"BL Fiebich","year":"2000","unstructured":"Fiebich BL, Schleicher S, Butcher RD, Craig A, Lieb K (2000) The neuropeptide substance P activates p38 mitogen-activated protein kinase resulting in IL-6 expression independently from NF-\u03baB. J Immunol 165:5606\u20135611","journal-title":"J Immunol"},{"key":"1030_CR11","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.4049\/jimmunol.159.10.4952","volume":"159","author":"K Lieb","year":"1997","unstructured":"Lieb K, Fiebich BL, Berger M, Bauer J, Schulze-Osthoff K (1997) The neuropeptide substance P activates transcription factor NF-kappa B and kappa B-dependent gene expression in human astrocytoma cells. J Immunol 159:4952\u20134958","journal-title":"J Immunol"},{"key":"1030_CR12","doi-asserted-by":"crossref","first-page":"26545","DOI":"10.1074\/jbc.M003990200","volume":"275","author":"I Castagliuolo","year":"2000","unstructured":"Castagliuolo I, Valenick L, Liu J, Pothoulakis C (2000) Epidermal growth factor receptor transactivation mediates substance P-induced mitogenic responses in U-373 MG cells. J Biol Chem 275:26545\u201326550","journal-title":"J Biol Chem"},{"key":"1030_CR13","doi-asserted-by":"crossref","first-page":"11312","DOI":"10.1074\/jbc.275.15.11312","volume":"275","author":"WE Miller","year":"2000","unstructured":"Miller WE, Maudsley S, Ahn S, Khan KD, Luttrell LM, Lefkowitz RJ (2000) \u03b2-Arrestin1 interacts with the catalytic domain of the tyrosine kinase c-SRC. J Biol Chem 275:11312\u201311319","journal-title":"J Biol Chem"},{"key":"1030_CR14","first-page":"855","volume":"55","author":"ED Roush","year":"1999","unstructured":"Roush ED, Warabi K, Kwatra MM (1999) Characterization of differences between rapid agonist-dependent phosphorylation and phorbol ester-mediated phosphorylation of human substance P receptor in intact cells. Mol Pharmacol 55:855\u2013862","journal-title":"Mol Pharmacol"},{"key":"1030_CR15","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0014-5793(98)00553-5","volume":"428","author":"ED Roush","year":"1998","unstructured":"Roush ED, Kwatra MM (1998) Human substance P receptor expressed in Chinese hamster ovary cells directly activates G\u03b1q\/11, G\u03b1s, and G\u03b1o. FEBS Lett 428:291\u2013294","journal-title":"FEBS Lett"},{"key":"1030_CR16","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1038\/sj.onc.1204184","volume":"20","author":"KL Pierce","year":"2001","unstructured":"Pierce KL, Luttrell LM, Lefkowitz RJ (2001) New mechanisms in heptahelical receptor signaling to mitogen activated protein kinase cascades. Oncogene 20:1532\u20131539","journal-title":"Oncogene"},{"key":"1030_CR17","doi-asserted-by":"crossref","first-page":"11086","DOI":"10.1073\/pnas.190276697","volume":"97","author":"KA DeFea","year":"2000","unstructured":"DeFea KA, Vaughn ZD, O\u2019Bryan EM, Nishijima D, D\u00e9ry O, Bunnett NW (2000) The antiproliferative and antiapoptotic effects of substance P are facilitated by formation of a \u03b2-arrestin-dependent scaffolding complex. Proc Natl Acad Sci USA 97:11086\u201311091","journal-title":"Proc Natl Acad Sci USA"},{"key":"1030_CR18","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1021\/jm970124v","volume":"40","author":"P Traxler","year":"1997","unstructured":"Traxler P, Bold G, Frei J, Lang N, Mett H, Buchdunger E, Meyer T, Mueller M, Furet P (1997) Use of a pharmacophore model for the design of EGF-R tyrosine kinase inhibitors: 4-(phenylamino)pyrazolo[3,4-d]pyrimidines. J Med Chem 40:3601\u20133616","journal-title":"J Med Chem"},{"key":"1030_CR19","doi-asserted-by":"crossref","first-page":"C1498","DOI":"10.1152\/ajpcell.2001.280.6.C1498","volume":"280","author":"C Benes","year":"2001","unstructured":"Benes C, Soltoff SP (2001) Modulation of PKC\u03b4 tyrosine phosphorylation and activity in salivary and PC-12 cells by Src kinases. Am J Physiol Cell Physiol 280:C1498\u2013C1510","journal-title":"Am J Physiol Cell Physiol"},{"key":"1030_CR20","doi-asserted-by":"crossref","first-page":"35220","DOI":"10.1074\/jbc.M303119200","volume":"278","author":"JA Tapia","year":"2003","unstructured":"Tapia JA, Garc\u00eda-Marin LJ, Jensen RT (2003) Cholecystokinin-stimulated protein kinase C-\u03b4 kinase activation, tyrosine phosphorylation, and translocation are mediated by Src tyrosine kinases in pancreatic acinar cells. J Biol Chem 278:35220\u201335230","journal-title":"J Biol Chem"},{"key":"1030_CR21","doi-asserted-by":"crossref","first-page":"C798","DOI":"10.1152\/ajpcell.00465.2003","volume":"286","author":"P Robin","year":"2004","unstructured":"Robin P, Boulven I, Bole-Feysot C, Tanfin Z, Leiber D (2004) Contribution of PKC-dependent and -independent processes in temporal ERK regulation by ET-1, PDGF, and EGF in rat myometrial cells. Am J Physiol Cell Physiol 286:C798\u2013C806","journal-title":"Am J Physiol Cell Physiol"},{"key":"1030_CR22","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/jcp.20052","volume":"201","author":"S Greco","year":"2004","unstructured":"Greco S, Muscella A, Elia MG, Romano S, Storelli C, Marsigliante S (2004) Mitogenic signalling by B2 bradykinin receptor in epithelial breast cells. J Cell Physiol 201:84\u201396","journal-title":"J Cell Physiol"},{"key":"1030_CR23","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0165-6147(98)01184-5","volume":"19","author":"M Treiman","year":"1998","unstructured":"Treiman M, Caspersen C, Christensen SB (1998) A tool coming of age: thapsigargin as an inhibitor of sarco-endoplasmic reticulum Ca2+-ATPases. Trends Pharmacol Sci 19:131\u2013135","journal-title":"Trends Pharmacol Sci"},{"key":"1030_CR24","first-page":"327","volume":"8","author":"TG Parmer","year":"1997","unstructured":"Parmer TG, Ward MD, Hait WN (1997) Effects of rottlerin, an inhibitor of calmodulin-dependent protein kinase III, on cellular proliferation, viability, and cell cycle distribution in malignant glioma cells. Cell Growth Diff 8:327\u2013334","journal-title":"Cell Growth Diff"},{"key":"1030_CR25","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0065-230X(08)60774-5","volume":"76","author":"JS Biscardi","year":"1999","unstructured":"Biscardi JS, Tice DA, Parsons SJ (1999) c-Src, receptor tyrosine kinases and human cancer. Adv Cancer Res 76:61\u2013119","journal-title":"Adv Cancer Res"},{"key":"1030_CR26","first-page":"269","volume":"8","author":"CA Staley","year":"1997","unstructured":"Staley CA, Parikh NU, Gallick GE (1997) Decreased tumorigenicity of a human colon adenocarcinoma cell line by an antisense expression vector specific for c-Src. Cell Growth Diff 8:269\u2013274","journal-title":"Cell Growth Diff"},{"key":"1030_CR27","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/5971","volume":"21","author":"RB Irby","year":"1999","unstructured":"Irby RB, Mao W, Coppola D, Kang J, Loubeau JM, Trudeau W, Karl R, Fujita DJ, Jove R, Yeatman TJ (1999) Activating SRC mutation in a subset of advanced human colon cancers. Nat Genet 21:187\u2013190","journal-title":"Nat Genet"},{"key":"1030_CR28","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0165-6147(00)01567-4","volume":"21","author":"M Susa","year":"2000","unstructured":"Susa M, Missbach M, Green J (2000) Src inhibitors: drugs for the treatment of osteoporosis, cancer or both. Trends Pharmacol Sci 21: 489\u2013495","journal-title":"Trends Pharmacol Sci"},{"key":"1030_CR29","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/nrc1366","volume":"4","author":"TJ Yeatman","year":"2004","unstructured":"Yeatman TJ (2004) A renaissance for Src. Nat Rev Cancer 4: 470\u2013480","journal-title":"Nat Rev Cancer"},{"key":"1030_CR30","doi-asserted-by":"crossref","first-page":"13754","DOI":"10.1016\/S0021-9258(18)67084-X","volume":"261","author":"N Rosen","year":"1986","unstructured":"Rosen N, Bolen JB, Schwartz AM, Cohen P, DeSeau V, Israel MA (1986) Analysis of pp60c-src protein kinase activity in human tumor cell lines and tissues. J Biol Chem 261:13754\u201313759","journal-title":"J Biol Chem"},{"key":"1030_CR31","doi-asserted-by":"crossref","first-page":"22348","DOI":"10.1074\/jbc.M003203200","volume":"275","author":"IM Hussaini","year":"2000","unstructured":"Hussaini IM, Karns LR, Vinton G, Carpenter JE, Redpath GT, Sando JJ, VandenBerg SR (2000) Phorbol 12-myristate 13-acetate induces protein kinase C\u03b7 - specific proliferative response in astrocytic tumor cells. J Biol Chem 275:22348\u201322354","journal-title":"J Biol Chem"},{"key":"1030_CR32","first-page":"4612","volume":"61","author":"R Mandil","year":"2001","unstructured":"Mandil R, Ashkenazi E, Blass M, Kronfeld I, Kazimirsky G, Rosenthal G, Umansky F, Lorenzo PS, Blumberg PM, Brodie C (2001) Protein kinase C\u03b1 and protein kinase C\u03b4 play opposite roles in proliferation and apoptosis of glioma cells. Cancer Res 61:4612\u20134619","journal-title":"Cancer Res"},{"key":"1030_CR33","doi-asserted-by":"crossref","first-page":"23693","DOI":"10.1074\/jbc.M111658200","volume":"277","author":"A Zrachia","year":"2002","unstructured":"Zrachia A, Dobroslav M, Blass M, Kazimirsky G, Kronfeld I, Blumberg PM, Kobiler D, Lustig S, Brodie C (2002) Infection of glioma cells with sindbis virus induces selective activation and tyrosine phosphorylation of protein kinase C\u03b4. J Biol Chem 277:23693\u201323701","journal-title":"J Biol Chem"},{"key":"1030_CR34","doi-asserted-by":"crossref","first-page":"32544","DOI":"10.1074\/jbc.M301523200","volume":"278","author":"S Kambhampati","year":"2003","unstructured":"Kambhampati S, Li Y, Verma A, Sassano A, Majchrzak B, Deb DK, Parmer S, Giafis N, Kalvakolanu DV, Rahman A, Uddin S, Minucci S, Tallman MS, Fish EN, Platanias LC (2003) Activation of protein kinase C\u03b4 by all-trans-retinoic acid. J Biol Chem 278:32544\u201332551","journal-title":"J Biol Chem"},{"key":"1030_CR35","doi-asserted-by":"crossref","first-page":"5888","DOI":"10.1128\/MCB.18.10.5888","volume":"18","author":"W Li","year":"1998","unstructured":"Li W, Jiang Y-X, Zhang J, Soon L, Flechner L, Kapoor V, Pierce JH, Wang L-H (1998) Protein kinase C-\u03b4 is an important signaling molecule in insulin-like growth factor I receptor-mediated cell transformation. Mol Cell Biol 18:5888\u20135898","journal-title":"Mol Cell Biol"},{"key":"1030_CR36","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1096\/fj.03-0979rev","volume":"18","author":"DN Jackson","year":"2004","unstructured":"Jackson DN, Foster DA (2004) The enigmatic protein kinase C\u03b4: complex roles in cell proliferation and survival. FASEB J 18:627\u2013636","journal-title":"FASEB J"},{"key":"1030_CR37","doi-asserted-by":"crossref","first-page":"C1281","DOI":"10.1152\/ajpcell.00202.2003","volume":"286","author":"R Ginnan","year":"2004","unstructured":"Ginnan R, Pfleiderer PJ, Pumiglia K, Singer HA (2004) PKC- and CaMKII-\u03b42 mediate ATP-dependent activation of ERK1\/2 in vascular smooth muscle. Am J Physiol Cell Physiol 286:C1281\u2013C1289","journal-title":"Am J Physiol Cell Physiol"},{"key":"1030_CR38","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1006\/bbrc.1994.1199","volume":"199","author":"M Gschwendt","year":"1994","unstructured":"Gschwendt M, M\u00fcller H-J, Kielbassa K, Zang R, Kittstein W, Rincke G, Marks F (1994) Rottlerin, a novel protein kinase inhibitor. Bioch Biochem Biophys Res Commun 199:93\u201398","journal-title":"Biochem Biophys Res Commun"},{"key":"1030_CR39","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3171\/jns.2001.95.3.0472","volume":"95","author":"M Nagane","year":"2001","unstructured":"Nagane M, Narita Y, Mishima K, Levitzki A, Burgess AW, Cavenee WK, Huang HJ (2001) Human glioblastoma xenografts overexpressing a tumor-specific mutant epidermal growth factor receptor sensitized to cisplatin by the AG1478 tyrosine kinase inhibitor. J Neurosurg 95: 472\u2013479","journal-title":"J Neurosurg"},{"key":"1030_CR40","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.bcp.2003.12.035","volume":"67","author":"T Efferth","year":"2004","unstructured":"Efferth T, Ramirez T, Gebhart E, Halatsch ME (2004) Combination treatment of glioblastoma multiforme cell lines with the anti-malarial artesunate and epidermal growth factor receptor tyrosine kinase inhibitor OSI-774. Biochem Pharmacol 67:1689\u20131700","journal-title":"Biochem Pharmacol"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-005-1030-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-005-1030-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-005-1030-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T18:41:12Z","timestamp":1683139272000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-005-1030-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7,13]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["1030"],"URL":"https:\/\/doi.org\/10.1007\/s00280-005-1030-3","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,7,13]]}}}